Evidence map›Paper›PMID 31131875›Full record

ArticleBiotechnology and bioengineering2019

Micropatterned substrates with physiological stiffness promote cell maturation and Pompe disease phenotype in human induced pluripotent stem cell-derived skeletal myocytes.

Nunnapas Jiwlawat, Eileen M Lynch, Brett N Napiwocki, Alana Stempien, Randolph S Ashton, Timothy J Kamp, Wendy C Crone, Masatoshi Suzuki

Open access · greenAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Induced pluripotent stem cell for modeling Pompe disease.Frontiers in cardiovascular medicine · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nunnapas JiwlawatDepartment of Comparative Biosciences, University of Wisconsin, Madison, Wisconsin.ORCID 0000-0002-5147-2900
Eileen M LynchDepartment of Comparative Biosciences, University of Wisconsin, Madison, Wisconsin.
Brett N NapiwockiWisconsin Institute for Discovery, University of Wisconsin, Madison, Wisconsin.
Alana StempienWisconsin Institute for Discovery, University of Wisconsin, Madison, Wisconsin.
Randolph S AshtonWisconsin Institute for Discovery, University of Wisconsin, Madison, Wisconsin.
Timothy J KampDepartment of Medicine, University of Wisconsin, Madison, Wisconsin.
Wendy C CroneWisconsin Institute for Discovery, University of Wisconsin, Madison, Wisconsin.
Masatoshi SuzukiDepartment of Comparative Biosciences, University of Wisconsin, Madison, Wisconsin.ORCID 0000-0003-3253-0711
University of Wisconsin–Madison · USUniversity of Wisconsin System · US

Funding

Muscle stem cells: New ALS growth factor therapy and disease modelR01NS091540 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SUZUKI, MASATOSHI · 2015 to 2019
$1.7M
NINDS NIH HHS R01 NS091540
6 · The paper itself

Abstract

Recent advances in bioengineering have enabled cell culture systems that more closely mimic the native cellular environment. Here, we demonstrated that human induced pluripotent stem cell (iPSC)-derived myogenic progenitors formed highly-aligned myotubes and contracted when seeded on two-dimensional micropatterned platforms. The differentiated cells showed clear nuclear alignment and formed elongated myotubes dependent on the width of the micropatterned lanes. Topographical cues from micropatterning and physiological substrate stiffness improved the formation of well-aligned and multinucleated myotubes similar to myofibers. These aligned myotubes exhibited spontaneous contractions specifically along the long axis of the pattern. Notably, the micropatterned platforms developed bundle-like myotubes using patient-derived iPSCs with a background of Pompe disease (glycogen storage disease type II) and even enhanced the disease phenotype as shown through the specific pathology of abnormal lysosome accumulations. A highly-aligned formation of matured myotubes holds great potential in further understanding the process of human muscle development, as well as advancing in vitro pharmacological studies for skeletal muscle diseases.

Indexed as

Glycogen Storage Disease Type IIHumansInduced Pluripotent Stem CellsMuscle Fibers, Skeletalhuman induced pluripotent stem cellsin vitro modelingmicropatternPompe diseaseskeletal myocytessubstrate stiffness

Identifiers

PMID31131875
PMCPMC6699746
OpenAlexW2947673470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.